Partial purification and amino acid sequence analysis of endometriosis protein-II (ENDO-II) reveals homology with tissue inhibitor of metalloproteinases-1 (TIMP-1).
article
OA: closed
CC0
⤵ 32 in-corpus citations
AI-generated summary
Endometriosis protein-II (ENDO-II) was partially purified from rat endometriotic tissue, and amino acid sequencing revealed homology with tissue inhibitor of metalloproteinases-1 (TIMP-1).
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
De novo synthesized endometriosis protein-II (ENDO-II; M(r) 28,000 to 32,000; pI 7.0 to 9.0) was partially purified from rat endometriotic tissue culture media using affinity chromatography and two-dimensional SDS-PAGE. The protein was electrophoretically transferred to polyvinyl difluoride membranes which were stained with Coomassie blue R-250. The stained protein corresponding to ENDO-II (M(r) 28,000 to 32,000; pI 7.0 to 9.0) was cut from the membranes for amino acid sequencing. Partial amino acid sequence was determined by automated Edman degradation using a gas phase sequencer and phenylthiohydantoin analyzer. Sequence analysis of ENDO-II yielded 25 residues: C S C A P T H P Q T A F C N S D L V I R K F M G. Comparison to sequence databanks demonstrated significant homology with rat (100%) and human (84%) tissue inhibitor of metalloproteinases-1 (TIMP-1). Western blot analysis using a TIMP-1 antibody confirmed amino acid sequence analysis. In conclusion, ENDO-II shares sequence homology with TIMP-1 and cross-reactivity with TIMP-1 antibody and subsequently identifies production of TIMP-1 by endometriotic tissues. The synthesis and secretion of TIMP-1 by endometriosis may derange the normal proteolytic milieu of the peritoneal cavity and contribute to the etiology and underlying physiological sequelae associated with the disease endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
Cited by (32)
- IL-10 is not anti-fibrotic but pro-fibrotic in endometriosis: IL-10 treatment of endometriotic stromal cells in vitro promotes myofibroblast proliferation and collagen type I protein expression 2022
- Proteomic analysis of peritoneal fluid identified COMP and TGFBI as new candidate biomarkers for endometriosis 2021
- Cervical mucus proteome in endometriosis 2017
- Endometriosis 2015
- Cellular and molecular basis for endometriosis-associated infertility 2012
- TIMP1 Contributes to Ovarian Anomalies in Both an MMP-Dependent and -Independent Manner in a Rat Model1 2011
- Cinética celular na endometriose profunda infiltrativa de reto-sigmoide: estudo anátomo-clínico 2011
- Post-Translational Modifications and Protein-Specific Isoforms in Endometriosis Revealed by 2D DIGE 2010
- Reduced Fecundity in Female Rats with Surgically Induced Endometriosis and in Their Daughters: A Potential Role for Tissue Inhibitors of Metalloproteinase 11 2008
- Use of proteomic analysis of endometriosis to identify different protein expression in patients with endometriosis versus normal controls 2006
- Aromatase in endometriosis and uterine leiomyomata 2005
- mRNA analysis of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis using a real-time quantitative RT–PCR assay 2004
- Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis 2003
- Mechanisms of excessive estrogen formation in endometriosis 2002
- Diagnostik und Therapie der Endometriose 2002
- Estrogen Production and Metabolism in Endometriosis 2002
- Using Rats as a Research Model for the Study of Endometriosis 2002
- Paracrine Regulation of Matrix Metalloproteinase Expression in Endometriosis 2002
- Differential Regulation of Matrix Metalloproteinase-3 Gene Expression in Endometriotic Lesions Compared with Endometrium1 2001
- Endometrial Anomalies in Women with Endometriosis 2001
- Angiogenesis in Endometriosis 2001
- Aromatase as a Therapeutic Target in Endometriosis 2000
- Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance 2000
- Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis. 1999
- Peritoneal endometriotic lesions differentially express a haptoglobin-like gene* 1999
- Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target 1999
- Novel Implications in the Development of Endometriosis: Biphasic Effect of Macrophage Activation on Peritoneal Tissue Expression of Tissue Inhibitor of Metalloproteinase‐1 1998
- Tissue Inhibitor of Metalloproteinase-1 Concentrations are Attenuated in Peritoneal Fluid and Sera of Women with Endometriosis and Restored in Sera by Gonadotropin-Releasing Hormone Agonist Therapy 1998
- Deficient 17β-Hydroxysteroid Dehydrogenase Type 2 Expression in Endometriosis: Failure to Metabolize 17β-Estradiol<sup>1</sup> 1998
- PATHOGENESIS OF ENDOMETRIOSIS 1997
- BASIC RESEARCH IN ENDOMETRIOSIS 1997
- Expression of interstitial collagenase (matrix metalloproteinase-1) is related to the activity of human endometriotic lesions 1997
Source provenance
- europepmc
- last seen: 2026-08-21T06:14:13.963979+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:11:08.331550+00:00
- unpaywall
- last seen: 2026-08-21T06:37:11.537704+00:00
License: CC0
· commercial use OK